Scientists trace new Drug's journey through the body
NCT ID NCT07494175
Summary
This early-stage study aims to understand what happens to a new drug, HRS-9190, after it's given to people. Six healthy male volunteers will receive a single dose containing a tiny, safe amount of radioactive tracer. Researchers will then carefully measure how the drug is absorbed, broken down, and removed from the body through urine and feces.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY ADULT MALE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
First Affiliated Hospital of Shandong First Medical University (Shandong Provincial Qianfoshan Hospital)
Jinan, Shandong, 250014, China
Contact
Contact
Conditions
Explore the condition pages connected to this study.